NASDAQ: EYPTEyepoint Inc Stock Ownership - Who owns Eyepoint?
Insider buying vs selling
Have Eyepoint Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Karen L. Zaderej | Director | 2026-08-18 | 10,600 | $4.93 | $52.26kBuy |
| Jay S. Duker | CEO;Pres | 2026-07-10 | 8,059 | $14.72 | $118.63kSell |
| Ramiro Ribeiro | Chief Medical Officer | 2026-06-30 | 2,437 | $8.26 | $20.13kBuy |
| Ramiro Ribeiro | Chief Medical Officer | 2026-06-30 | 2,438 | $8.26 | $20.14kBuy |
| Ramiro Ribeiro | Chief Medical Officer | 2026-06-30 | 2,438 | $15.02 | $36.61kSell |
| Ramiro Ribeiro | Chief Medical Officer | 2026-06-30 | 2,437 | $15.00 | $36.56kSell |
| George Elston | Chief Financial Officer | 2026-05-25 | 3,627 | $12.93 | $46.90kSell |
| Ramiro Ribeiro | Chief Medical Officer | 2026-04-17 | 2,437 | $15.00 | $36.56kSell |
| Ramiro Ribeiro | Chief Medical Officer | 2026-04-17 | 2,437 | $8.26 | $20.13kBuy |
| Jay S. Duker | President and CEO | 2026-03-23 | 76,766 | $13.11 | $1.01MSell |
EYPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EYPT insiders and whales buy or sell their stock.
EYPT Shareholders
What type of owners hold Eyepoint Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ew Healthcare Partners LP | 101.26% | 87,298,833 | $371.02M | Insider |
| Pfizer Inc | 86.40% | 74,483,748 | $316.56M | Insider |
| Ronald W. Eastman | 19.97% | 17,212,648 | $73.15M | Insider |
| Cormorant Asset Management LP | 19.24% | 16,590,000 | $70.51M | Insider |
| Adage Capital Management LP | 5.98% | 5,156,299 | $21.91M | Insider |
| Paul Ashton | 0.56% | 484,303 | $2.06M | Insider |
| Nancy Lurker | 0.49% | 421,235 | $1.79M | Insider |
| Jay S. Duker | 0.24% | 209,525 | $890.48k | Insider |
| David J. Mazzo | 0.23% | 200,083 | $850.35k | Insider |
| George Elston | 0.18% | 152,470 | $648.00k | Insider |
EYPT vs Biotech Stocks
Eyepoint Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.